Greenwich LifeSciences reported cash from operations of -$1.94M and free cash flow of -$1.94M for the quarter ended Jun 2026, up 13.1% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -3.75M | -3.71M | -9.15M | -5.66M | -3.95M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortization of IntangiblesAmort. of Intangibles | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 876.00 | ||||||||||||
| Share-based CompensationStock Comp. | 0.17M | 0.17M | 0.17M | 0.22M | 0.76M | 0.59M | 1.84M | 0.59M | -0.65M | 0.59M | 0.59M | 0.59M | 0.59M | 5.47M | 1.54M | 1.54M | 1.54M | 2.17M | 1.54M | 1.48M | ||||||||
| Gains from Investment SecuritiesGains Investment | 2.91M | |||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.33M | -0.08M | -0.07M | 0.03M | 0.09M | 0.99M | 0.55M | 2.03M | -0.64M | 0.76M | -0.19M | 2.14M | -0.37M | 0.52M | ||||||||||||||
| Change in Accrued ExpensesChange Accrued Exp. | 0.06M | 0.01M | -0.14M | -0.01M | 0.01M | 0.03M | -0.03M | -0.01M | 0.07M | -0.03M | 0.00M | -0.03M | 0.05M | 0.01M | 0.01M | 0.00M | 0.12M | 0.07M | -0.22M | 0.00M | ||||||||
| Cash from OperationsCash from Ops. | -0.89M | -2.26M | -1.95M | -0.53M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.78M | -1.05M | -2.58M | -1.85M | -1.83M | -2.23M | -2.67M | -3.17M | -4.70M | -1.94M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||
| Long-Term Debt RepaymentsLT Debt Repayment | 5.51M | 2.02M | ||||||||||||||||||||||||||
| Net Long-Term Debt Issued (Repaid)Net LT Debt | -5.51M | -2.02M | ||||||||||||||||||||||||||
| Net Debt Issuances and RepaymentsNet Debt Issuance | -5.51M | -2.02M | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Common Stock IssuedStock Issued | 0.56M | 0.30M | 2.77M | 1.18M | 0.12M | 0.49M | 2.61M | 3.35M | 5.55M | 9.03M | ||||||||||||||||||
| Shares Repurchased | 5.51M | 2.02M | 0.52M | |||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.56M | -5.51M | -2.02M | -0.52M | 0.30M | 2.77M | 1.18M | 0.12M | 0.49M | 2.61M | 3.35M | 5.55M | 9.03M | |||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.56M | -5.51M | -2.02M | -0.52M | 0.30M | 2.77M | 1.18M | 0.12M | 0.49M | 2.61M | 3.35M | 5.55M | 9.03M | |||||||||||||||
| Other financing activities (as filed) | 0.03M | 0.07M | 0.07M | |||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.56M | -5.51M | -2.02M | 0.30M | 2.77M | 1.18M | 0.12M | 0.49M | 2.61M | 3.35M | 5.55M | 9.03M | 0.31M | |||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | -0.89M | -1.70M | -7.46M | -2.56M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.48M | 1.72M | -1.40M | -1.73M | -1.34M | 0.38M | 0.68M | 2.37M | 4.33M | -1.63M | ||||||||
| Ending Cash Balance | 28.91M | 27.20M | 19.74M | 17.19M | 15.64M | 13.47M | 11.91M | 10.94M | 9.14M | 6.99M | 5.51M | 7.22M | 5.82M | 4.09M | 2.75M | 3.13M | 3.81M | 6.18M | 10.51M | 8.88M | ||||||||
| Free Cash FlowFCF | -0.89M | -2.26M | -1.95M | -0.53M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.78M | -1.05M | -2.58M | -1.85M | -1.83M | -2.23M | -2.67M | -3.17M | -4.70M | -1.94M | ||||||||
| Net Cash FlowNCF | -0.89M | -1.70M | -7.46M | -2.56M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.48M | 1.72M | -1.40M | -1.73M | -1.34M | 0.38M | 0.68M | 2.37M | 4.33M | -1.63M |
Pull Greenwich LifeSciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=GLSI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "GLSI", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=GLSI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();